Introduction.
PMM2-CDG is the most frequent CDG with more than 900 reported patients.
It is a multisystem disease with variable phenotype [1]. Renal
involvement is described in only 6 % affected patients [2] with
only a few describing nephrotic syndrome (NS) [3-6].